SCHEMBL20174447

SCHEMBL20174447

c1ccc(-c2cc(-c3cccc4ccccc34)nc(-c3cccc4c3-c3sc5ccccc5c3C43c4ccccc4-c4ccccc43)n2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
SMN1; SMN2 Q16637 4/20 0.33
MAPT P10636 3/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
KDM4E B2RXH2 1/20 0.33
TP53 P04637 1/20 0.33
TSHR P16473 1/20 0.33
NFKB1 P19838 1/20 0.33
MAPK1 P28482 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
ATM Q13315 1/20 0.33
HSD17B10 Q99714 1/20 0.33
ADORA1 P30542 1/20 0.31
CYP1A2 P05177 2/20 0.31
CYP2C9 P11712 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20174471 0.93 ALOX5 (0.33) MEN1KMT2ASMN1; SMN2MAPTALDH1A1
SCHEMBL20174464 0.91 KDM4E (0.33) MEN1KMT2ASMN1; SMN2MAPTALDH1A1
SCHEMBL20174470 0.89 MEN1 (0.32) MEN1KMT2A
SCHEMBL20174515 0.87 MEN1 (0.32) MEN1KMT2ASMN1; SMN2MAPTALDH1A1
SCHEMBL20174505 0.86 MEN1 (0.36) MEN1KMT2ASMN1; SMN2MAPTALDH1A1
SCHEMBL20174459 0.86 MEN1 (0.31) MEN1KMT2ASMN1; SMN2MAPTALDH1A1
SCHEMBL20174487 0.86 ALOX5 (0.33) MEN1KMT2ASMN1; SMN2MAPTALDH1A1
SCHEMBL20174475 0.86 ENPP3 (0.32) SMN1; SMN2MAPTALDH1A1HPGDL3MBTL1
SCHEMBL20174466 0.85 ALDH1A1 (0.33) MEN1KMT2ASMN1; SMN2MAPTALDH1A1
SCHEMBL20174463 0.85 KDM4E (0.35) MEN1KMT2ASMN1; SMN2MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738034-B2 Spiro compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2020-08-11 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738034-B2 Spiro compound and organic light-emitting device comprising same CRY1, NR2E3, ERG MEN1 611/4885KMT2A 1480/4885SMN1; SMN2 3407/4885
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, NR2E3, ERG MEN1 611/4885KMT2A 1480/4885SMN1; SMN2 3407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.